548 related articles for article (PubMed ID: 19685375)
1. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
[TBL] [Abstract][Full Text] [Related]
2. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
3. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
Hamazaki K; Itomura M; Huan M; Nishizawa H; Sawazaki S; Tanouchi M; Watanabe S; Hamazaki T; Terasawa K; Yazawa K
Nutrition; 2005 Jun; 21(6):705-10. PubMed ID: 15925295
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
[TBL] [Abstract][Full Text] [Related]
5. Influence of very long-chain n-3 fatty acids on plasma markers of inflammation in middle-aged men.
Yusof HM; Miles EA; Calder P
Prostaglandins Leukot Essent Fatty Acids; 2008 Mar; 78(3):219-28. PubMed ID: 18403189
[TBL] [Abstract][Full Text] [Related]
6. Influence of n-3 polyunsaturated fatty acids on soluble cellular adhesion molecules as biomarkers of cardiovascular risk in young healthy subjects.
Paulo MC; Andrade AM; Andrade ML; Morais MG; Kiely M; Parra D; Martinéz JA; Thorsdottir I; Bandarra NM
Nutr Metab Cardiovasc Dis; 2008 Dec; 18(10):664-70. PubMed ID: 18420395
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma levels of tissue factor pathway inhibitor (TFPI) after n-3 polyunsaturated fatty acids supplementation in patients with chronic atherosclerotic disease.
Berrettini M; Parise P; Ricotta S; Iorio A; Peirone C; Nenci GG
Thromb Haemost; 1996 Mar; 75(3):395-400. PubMed ID: 8701396
[TBL] [Abstract][Full Text] [Related]
8. Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study.
Dyerberg J; Eskesen DC; Andersen PW; Astrup A; Buemann B; Christensen JH; Clausen P; Rasmussen BF; Schmidt EB; Tholstrup T; Toft E; Toubro S; Stender S
Eur J Clin Nutr; 2004 Jul; 58(7):1062-70. PubMed ID: 15220949
[TBL] [Abstract][Full Text] [Related]
9. [Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination].
Zeman M; Zák A; Vecka M; Tvrzická E; Písaríková A; Stanková B
Cas Lek Cesk; 2005; 144(11):737-41. PubMed ID: 16335699
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
Davidson MH; Stein EA; Bays HE; Maki KC; Doyle RT; Shalwitz RA; Ballantyne CM; Ginsberg HN;
Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
12. Effects of modest doses of omega-3 fatty acids on lipids and lipoproteins in hypertriglyceridemic subjects. A randomized controlled trial.
Deck C; Radack K
Arch Intern Med; 1989 Aug; 149(8):1857-62. PubMed ID: 2669667
[TBL] [Abstract][Full Text] [Related]
13. Effect of eicosapentaenoic/docosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into different levels of lipidemia.
Castro IA; Monteiro VC; Barroso LP; Bertolami MC
Nutrition; 2007 Feb; 23(2):127-37. PubMed ID: 17234506
[TBL] [Abstract][Full Text] [Related]
14. The effect of n - 3 PUFA/gamma-cyclodextrin complex on serum lipids in healthy volunteers--a randomized, placebo-controlled, double-blind trial.
Kobayashi K; Hamazaki K; Fujioka S; Terao K; Yamamoto J; Kobayashi S
Asia Pac J Clin Nutr; 2007; 16(3):429-34. PubMed ID: 17704023
[TBL] [Abstract][Full Text] [Related]
15. Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II.
Garg ML; Blake RJ; Clayton E; Munro IA; Macdonald-Wicks L; Singh H; Moughan PJ
Eur J Clin Nutr; 2007 Nov; 61(11):1312-7. PubMed ID: 17299483
[TBL] [Abstract][Full Text] [Related]
16. Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects.
Goyens PL; Mensink RP
Eur J Clin Nutr; 2006 Aug; 60(8):978-84. PubMed ID: 16482073
[TBL] [Abstract][Full Text] [Related]
17. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination.
Zeman M; Zák A; Vecka M; Tvrzická E; Písaríková A; Stanková B
J Nutr Biochem; 2006 Jun; 17(6):379-84. PubMed ID: 16214329
[TBL] [Abstract][Full Text] [Related]
18. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses.
Leigh-Firbank EC; Minihane AM; Leake DS; Wright JW; Murphy MC; Griffin BA; Williams CM
Br J Nutr; 2002 May; 87(5):435-45. PubMed ID: 12010583
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of marine n-3 fatty acid formulations.
Dyerberg J; Madsen P; Møller JM; Aardestrup I; Schmidt EB
Prostaglandins Leukot Essent Fatty Acids; 2010 Sep; 83(3):137-41. PubMed ID: 20638827
[TBL] [Abstract][Full Text] [Related]
20. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
